Tcr2 Therapeutics

Developer of pharmaceutical products that focused on engineering T cells for cancer therapy

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups58 employees language tcr2.com

Registered entities

Investor mix

17 investors on record; lead investors include F2 Ventures, 6 Dimensions Capital, Curative Ventures; 1 has since exited.

Investor typeCountShare
Venture capital953%
Private equity212%
Bank & private debt212%
Other / undisclosed424%
Coming soon